BEHAVIOURAL SCIENCE IN CANCER SCREENING, CONTROL AND COMMUNICATION
With
Dr Rachael Dodd
Senior Research Fellow,
The Daffodil Centre, a Cancer Council NSW & The University of Sydney Joint Venture
Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney | April 2025
Dr Dodd completed her undergraduate in Psychology (2007), Masters in Health Psychology (2009) and PhD in Psychology (2016) in the UK. Her PhD focused on the psychosocial impact of HPV in people diagnosed with head and neck cancer, which resulted in the development of an education resource which is being implemented into clinical practice here in Australia and is available online. Dr Dodd relocated to The University of Sydney in Australia in 2017, following the completion of her PhD. Her research capitalised on her expertise in HPV and focused on the changes to the cervical screening program that commenced in Australia in 2017.
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
Dr Dodd has published 78 research papers and is a CI on grants worth over $20 million. This has included being the lead investigator of an International Lung Cancer Foundation Young Investigator Grant, to co-design decision support tools for lung cancer screening in Australia and she is leading a consortium to develop the suite of information materials and education resources for the upcoming National Lung Cancer Screening Program.
Source: Supplied
You Might also like
-
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
-
Anaemia guidelines updated after 50 years
Professor Sant-Rayn Pasricha is the Acting Deputy Director at the Walter Eliza Hall Institute of Medical Research in Melbourne, Australia. He is also a clinical haematologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. From a young age, Prof Pasricha dreamed of becoming a doctor and found joy in learning about the human body and how to care for patients. After completing medical school, he developed a passion for working in low and middle-income countries, which led him to spend time working in East Timor, India, and Central Australia with First Nations communities.
-
Dr Lisa Melton
RESEARCH IN BRAIN COMPUTER INTERFACE
@ SYNCHRON
MELBOURNE, VICTORIA, AUSTRALIA